Preoperative clinical and paraclinical features and neck lymph metastasis in patients with follicular thyroid cancer undergoing surgery in National Hospital of Endocrinology

Tan Phat Le1, Ngoc Luong Tran1, Ngoc Tu Vu2, , Duy Ho Nguyen, Tuan Dat Nguyen
1 National Hospital of Endocrinology
2 Hanoi Medical University

Main Article Content

Abstract

Background: Follicular thyroid cancer has a low rate of lymph node metastasis compared to other types. However, cervical lymph node metastasis is a risk factor for recurrence and distant metastasis, affecting the patient's prognosis. The study aims to evaluate the clinicopathologic features and metastasis states of follicular thyroid carcinoma at National hospital of Endocrinology.


Methods: We conducted a retrospective cohort study of 64 follicular thyroid carcinoma patients treated by surgery at National hospital of Endocrinology from June 2017 to March 2019.


Results: The mean age was 45,5 ± 13,1 and the female/male ratio was 15/1. Most patients presented with an asymptomatic and had a unilateral tumor with mean diameter was 15, 09 ± 8,42 mm. 73,4% of tumors were classifled as TIRADS 4 on ultrasound. FNA was not of great significance for diagnosis of follicular thyroid carcinoma with undetermined  significance result in 40,6%. The overall rate of nodal metastasis was 29,7%, higher with cancer surgery in both lobes of the thyroid gland.


Conclusions: Follicular thyroid cancer has a higher rate of cervical lymph node metastasis in patients aged 55 years and older, with tumors in both lobes and larger than 2 cm. However, cervical lymph node metastasis in follicular thyroid cancer is lower than in other thyroid cancers and cytology is not of high value in preoperative diagnosis.

Article Details

References

1. Alfalah H, Cranshaw I, Jany T, et al. Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma. World J Surg. 2008;32:2623-26. doi:http://doi.org/10.1007/s00268-008-9742-2
2. Zaydfudim V, Feurer ID, Griffin MR, et al. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. 2008;144(6):1070-1078. doi:http://doi.org/10.1016/j.surg.2008.08.034
3. Aschebrook-Kilfoy B, Grogan RH, Ward MH, et al. Follicular Thyroid Cancer Incidence Patterns in the United States, 1980–2009. Thyroid®. 2013/08/01 2013;23(8):1015-1021. doi:http://doi.org/10.1089/thy.2012.0356
4. Kwak JY, Han KH, Yoon JH, et al. Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk. Radiology. 2011;260(3):892-899. doi:http://doi.org/10.1148/radiol.11110206
5. Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341-1346.
6. Su D-H, Chang T-C, Chang S-H. Prognostic factors on outcomes of follicular thyroid cancer. Journal of the Formosan Medical Association. 2019/07/01/ 2019;118(7):1144-1153. doi:https://doi.org/10.1016/j.jfma.2018.11.010
7. Nguyễn Xuân Hậu, Nguyễn Thị Phương Anh, Lê Văn Quảng. Đặc điểm lâm sàng, cận lâm sàng và tình trạng di căn của ung thư tuyến giáp thể nang. Khoa học và Công nghệ. 63(9):06-09. doi:https://doi.org/10.31276/VJST.63(9).06-09
8. Vuong HG, Duong UNP, Pham TQ, et al. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis. World Journal of Surgery. 2018/04/01 2018;42(4):1005-1017. doi:http://doi.org/10.1007/s00268-017-4206-1
9. Chow S-M, Law SCK, Au S-K, et al. Differentiated thyroid carcinoma: Comparison between papillary and follicular carcinoma in a single institute. Head & Neck. 2002;24(7):670-677. doi:https://doi.org/10.1002/hed.10080
10. D'Avanzo A, Treseler P, Ituarte PHG, et al. Follicular thyroid carcinoma: Histology and prognosis. Cancer. 2004;100(6):1123-1129. doi:https://doi.org/10.1002/cncr.20081
11. Hoang JK, Lee WK, Lee M, et al. US Features of Thyroid Malignancy: Pearls and Pitfalls. RadioGraphics. 2007;27(3):847-860. doi:http://doi.org/10.1148/rg.273065038
12. Nguyễn Xuân Phong. Nghiên cứu đặc điểm lâm sàng và một số xét nghiệm trong ung thư biểu mô tuyến giáp. Trường Đại học Y Hà Nội; 2011.
13. NGuyễn Xuân Hậu. Đặc điểm lâm sàng và tình trạng di căn hạch của vi ung thư tuyến giáp thể nhú. Y học Việt Nam. 2021;507(1):217-220.
14. Nguyễn Thị Quỳnh Giang, Nguyễn Văn Chủ, Đỗ Tiến Dũng, et al. Đặc điểm mô bệnh học của ung thư biểu mô tuyến giáp biệt hóa tại Bệnh viện Nội tiết trung ương năm 2023. Y học Việt Nam. 2023;540(3):9-12.